Cardarine (known under the lab code GW501516) was originally developed for use in medical practice. The drug was prescribed for patients with diabetes, obesity, high cholesterol and heart disease. The active agent belongs to the PPAR receptor agonists; the drug can be assigned to the group of selective PPAR modulators (SPPARMs). They are essential during treatment of cardiometabolic diseases caused by obesity.
Сardarine was created in 1992 for the treatment of cardiovascular diseases and diseases associated with improper metabolism. Scientific testing of the drug has demonstrated the high effectiveness of the medication for fat oxidation and further breakdown. Metabolic processes are not disturbed, but are normalized.
Cardarine is commonly used in sports for the disciplines needing exceptional stamina. During intense physical training, GW501516 maintains a regularly low heart rate for the purposes of effective training. In bodybuilding and fitness, Сardarine is used to achieve two main objectives:
• increase the intensity and duration of training;
• reduce fat deposits.
Often during heavy training the heart rate rises so much that athletes need to prematurely end the exercise. Cardarine keeps the heart rate at a lower value, which makes it possible to carry out 2-3 additional reps, providing the muscles with necessary loads to achieve the desired fitness result. The recovery period while taking Cardarine is significantly reduced. The drug is indispensable for athletes that prefer to do cardio after exhausting training.